Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Alios Biopharma starts phase I drug interaction study for AL-335

Aug. 3, 2015

Novavax reports data from phase II trial of quadrivalent seasonal influenza vaccine

Aug. 3, 2015

Alios Biopharma starts first-in-human study of HCV polymerase inhibitor AL-704

Aug. 3, 2015

Oragenics and Intrexon report positive activity for lantibiotics in C. difficile model

July 31, 2015

Astellas reports topline data from ACTIVE study of isavuconazole

July 30, 2015

Patient-derived antibody is active against Middle East Respiratory Syndrome

July 30, 2015

Oncolys BioPharma and Kagoshima University to jointly search for novel anti-HBV agents

July 30, 2015

DNDi and Takeda collaborate on aminopyrazole series for visceral leishmaniasis

July 30, 2015

FDA accepts for review NDA for grazoprevir/elbasvir for hepatitis C

July 29, 2015

Nanjing Sanhome patent reports anti-HCV agents

July 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...